TÜBINGEN, Germany, May 11, 2022 /PRNewswire/ Acousia Therapeutics GmbH will be presenting data on the company's clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd
/PRNewswire/ Acousia Therapeutics GmbH will be presenting data on the company s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd.